Skip to main content
Clinical Trials/NL-OMON23268
NL-OMON23268
Not yet recruiting
Not Applicable

Translational research for immune modulating and targeted therapy in advanced or metastatic non-small cell lung cancer, an exploratory NVALT study

VALT0 sites300 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
on-small cell lung cancerNiet-kleincellig longkanker
Sponsor
VALT
Enrollment
300
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
VALT

Eligibility Criteria

Inclusion Criteria

  • 1\.Eligible for immunotherapy or targeted treatment.
  • 2\.Written informed consent for registry of patient data and extra blood and tumor biopsy.

Exclusion Criteria

  • 1\.Without written informed consent patient will be adopted anonymously in the registry and will not take part of the study.
  • 2\.Patients with written informed consent for registry of patient data but no consent for extra blood and tumor biopsy will be excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials